Categories AlphaGraphs, Earnings, Health Care

Key highlights from Moderna’s (MRNA) Q1 2023 earnings results

Moderna, Inc. (NASDAQ: MRNA) reported first quarter 2023 earnings results today.

Total revenue was $1.9 billion, compared to $6.1 billion in the same period a year ago, mainly due to a drop in sales of the company’s COVID-19 vaccines.

Product sales were $1.8 billion, down 69% compared to the prior-year period, driven mainly by lower sales volume.

Net income was $79 million, or $0.19 per share, compared to $3.7 billion, or $8.58 per share, last year.  

The company expects total product sales in the first half of 2023 to be approx. $2 billion. For the second quarter of 2023, sales are expected to be $0.2-0.3 billion.

Most Popular

COST Earnings: A snapshot of Costco’s Q4 2023 financial results

Costco Wholesale Corporation (NASDAQ: COST), which operates a chain of membership warehouses, on Tuesday reported results for the fourth quarter of fiscal 2024. The company posted revenues of $78.9 billion

What to look for when McCormick & Co. (MKC) reports Q3 2023 earnings

Shares of McCormick & Company Inc. (NYSE: MKC) were down on Tuesday. The stock has fallen 19% over the past three months. The spices and seasonings maker is scheduled to report its

Cintas Corporation (CTAS) Q1 2024 Earnings: Key financials and quarterly highlights

Cintas Corporation (NASDAQ: CTAS) reported first quarter 2024 earnings results today. Revenue was $2.34 billion, up 8.1% from the same period last year. Organic revenue growth was also 8.1%. Net

Add Comment
Viewing Highlight